Author:
Layoun Michael E.,Wickramasinghe Chanaka D.,Peralta Maria V.,Yang Eric H.
Publisher
Springer Science and Business Media LLC
Reference79 articles.
1. Ansfield F, Klotz J, Nealon T, et al. A phase III study comparing the clinical utility of four regimens of 5-fluorouracil: a preliminary report. Cancer. 1977;39:34–40.
2. Lokich JJ. Infusional 5-FU: historical evolution, rationale, and clinical experience. Oncology. 1998;12:19–22.
3. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2012 incidence and mortality web-based report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2015.
4. Heidelberger C, Chaudhuri NK, Danneberg P, et al. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature. 1957;179(4561):663–6.
5. Cohen SS, Flaks JG, Barner HD, Loeb MR, Lichtenstein J. The mode of action of 5-fluorouracil and its derivatives. Proc Natl Acad Sci U S A. 1958;44(10):1004–12.
Cited by
72 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献